Circulating cell-free microRNAs (miRNAs) represent a major reservoir for biomarker
discovery. Unfortunately, their implementation in clinical practice is limited due to a profound …

Objective Circulating cell-free microRNAs (miRNAs) which consist of short-sequence RNAs
are released from cells into the blood stream and has emerged as new biomarkers in the …

Metastasis is responsible for the majority of cancer‐related deaths. Particularly, challenging
is the management of metastatic cancer of unknown primary site (CUP), whose tissue of …

Cytopathological analyses of bronchial washings (BWs) collected during fibre‐optic
bronchoscopy are often inconclusive for lung cancer diagnosis. To address this issue, we …

Advanced ovarian cancer is one of the most lethal gynecological tumor, mainly due to late
diagnoses and acquired drug resistance. MicroRNAs (miRNAs) are small-non coding RNA …

Enzyme replacement therapy (ERT) is a mainstay of treatment for Anderson–Fabry disease
(AFD), a pathology with negative effects on the heart and kidneys. However, no reliable …

Archival formalin-fixed paraffin-embedded (FFPE) tissues represent an extraordinary source
of smallRNAs, including microRNAs (miRNAs). Contrary to other RNA molecules, miRNAs …

MicroRNAs (miRNAs) are small non-coding RNA molecules that regulate translation and are
involved in many pathological processes. They have emerged as promising biomarkers for …

Adult neurogenesis may help overcome Alzheimer's disease; however, knowledge
concerning neurogenic markers in the human brain remains limited. Herein, we compared …

Metastasis is responsible for the majority of cancer-related deaths. Particularly challenging
is the management of metastatic cancer of unknown primary site (CUP), whose tissue-of …